ADACEL (Sanofi-Aventis Australia Pty Ltd)
Product name
ADACEL
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
197 working days (255)
Active ingredients
pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (adsorbed)
Registration type
EOI
Indication
ADACEL (suspension for injection) may now also be administered during pregnancy for prevention of pertussis in young infants via transplacental antibody transfer from the pregnant woman to the fetus.